Lille, France

Marc Devocelle

This inventor holds 1 USPTO granted patent. Top assignee: Sanofi-Synthelabo. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marc Devocelle. Retrieved from https://idiyas.com/inventor/marc-devocelle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marc Devocelle: Innovator in Optically Active Compounds

Introduction

Marc Devocelle is a notable inventor based in Lille, France. He has made significant contributions to the field of chemistry, particularly in the preparation of optically active compounds. His work has implications in various applications, including pharmaceuticals.

Latest Patents

Marc holds a patent for a "Method for preparing optically active .alpha.-substituted benzyl alcohols." This innovation showcases his expertise in organic chemistry and his commitment to advancing the field.

Career Highlights

Marc is currently employed at Sanofi-Synthelabo, a leading global healthcare company. His role there allows him to apply his innovative ideas in a practical setting, contributing to the development of new therapeutic solutions.

Collaborations

Throughout his career, Marc has collaborated with talented individuals such as Francine Agbossou and Jean-Robert Dormoy. These partnerships have fostered a creative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Marc Devocelle's work exemplifies the spirit of innovation in the field of chemistry. His contributions, particularly in the preparation of optically active compounds, highlight his role as a significant inventor in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…